GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$945M
AUM Growth
+$122M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$40.3M
2
+$38.7M
3
+$37.5M
4
ZYME icon
Zymeworks
ZYME
+$34.8M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$24.9M

Top Sells

1
+$25.8M
2
+$19.3M
3
+$15.3M
4
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$5.02M
5
RVLP
RVL Pharmaceuticals plc Ordinary Shares
RVLP
+$3.52M

Sector Composition

1 Healthcare 98.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$95.7M 8.8%
5,260,803
2
$80.1M 7.36%
2,000,000
+406,604
3
$78.8M 7.24%
2,190,742
+690,742
4
$69.8M 6.41%
2,485,000
+562,063
5
$67.6M 6.21%
2,000,000
+25,615
6
$61.2M 5.62%
2,466,744
+1,402,703
7
$57.5M 5.28%
1,454,700
+5,400
8
$46.8M 4.3%
3,086,053
+38,253
9
$40.3M 3.71%
+300,000
10
$38.7M 3.56%
+141,667
11
$37.5M 3.44%
+470,000
12
$28.9M 2.65%
300,000
-200,000
13
$23.4M 2.15%
300,000
14
$22.6M 2.07%
+605,056
15
$20.2M 1.85%
1,740,000
+736,400
16
$18.1M 1.66%
586,929
-837,069
17
$16.8M 1.54%
2,621,333
+1,068,433
18
$16.2M 1.49%
2,066,041
+389,791
19
$16.2M 1.49%
+270,000
20
$14.7M 1.35%
+250,000
21
$13M 1.19%
1,000,000
+657,936
22
$11.9M 1.1%
685,553
-8,700
23
$9.83M 0.9%
+125,000
24
$9.82M 0.9%
+301,979
25
$9.16M 0.84%
6,606
1
2